Nigerian Drugmakers Face Soaring Finance Costs Amid High Interest Rates

Nigerian pharmaceutical companies experienced a 47% surge in finance costs during Q1 2026, primarily due to high interest rates, which significantly impacted their profitability.

26 Jul, 00:08 — 26 Jul, 00:08

Post Share

Sources

Showing 1 of 1 sources

punch-ngMostly Factual2h ago

Drugmakers’ finance costs jump 47% amid high interest rates

Nigerian drugmakers’ finance costs surged by 47% in Q1 2026 due to high interest rates, impacting profitability. Learn how local pharma companies are navig Read More: https://punchng.com/drugmakers-finance-costs-jump-47-amid-high-interest-rates/

By Punch Newspapers

Read full article →

PERSPECTA

PERSPECTA

Nigerian Drugmakers Face Soaring Finance Costs Amid High Interest Rates

Sources

Drugmakers’ finance costs jump 47% amid high interest rates

Related Stories

Yemen's Houthis Target Saudi Oil Facilities Amid Regional Tensions

South Korea's Travel Account Records Third Consecutive Monthly Surplus

Sainsbury's Boosts British Salad Production Amid International Drought Concerns

Thailand seeks comprehensive biotechnology partnership with South Korea

PERSPECTA